Intensive care patients are experiencing loss of muscle mass because their muscles are unable to use fats for energy, according to a new study at the University College London. They can lose about 20 percent of their muscle mass in just 10 days.
Combination treatment that safely enhances the ability of the immune system to fight infections in the elderly population has been identified by a research team. Individuals who receive low doses of these drugs combines have lower incidence of infections for a year.
Bioengineers create pathway to personalized medicine by adding DNA instructions for individual's protein of interest to make a glycoprotein in CFGpS. The protein of choice could then be freeze-dried and reactivated for point-of-use synthesis by simply adding water.
New neurons archive old memories, a new that finds that reducing neurogenesis impairs recovery of learning capacity while promoting neurogenesis through physical activity increases hippocampal capacity claims.
Taming a fatal blood cancer becomes possible by blocking a target molecule on human acute myeloid leukemia (AML) cells in combination with other treatments; the cancerous blood cells died and are replaced by regenerating, healthy white blood cells.
Novel therapy that uses a single protein called called mitofusion 2 or Mfn2, which is found in the spinal cord, may delay muscle atrophy in Lou Gehrig's disease, according to a new study at the Case Western Reserve University.
Youth report improved wellbeing as result of tailored mental health services at the First Episode Mood and Anxiety Program (FEMAP) and reported that the benefits involve being empowered by feelings of self-acceptance.
Breast-conserving surgery may be recommended for women with multiple ipsilateral breast cancer instead of mastectomy, a new multi-institutional clinical trial at the Dartmouth-Hitchcock Medical Center.